A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis
Public ClinicalTrials.gov record NCT07277660. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the dose-response relationship of galvokimig compared with placebo in study participants with moderate-to-severe atopic dermatitis (AtD).
Study identification
- NCT ID
- NCT07277660
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 165 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 29, 2025 (Actual)
- Primary completion
- May 17, 2027 (Estimated)
- Completion
- Mar 6, 2028 (Estimated)
- Last update posted
- Sep 25, 2026
2025 – 2028
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Atd002 52021 | Oceanside | California | 92056 | — |
| Atd002 52008 | Santa Monica | California | 90403 | — |
| Atd002 52013 | Boca Raton | Florida | 33486 | — |
| Atd002 52007 | Miami | Florida | 33126 | — |
| Atd002 52003 | Miami | Florida | 33133 | — |
| Atd002 52015 | Savannah | Georgia | 31419 | — |
| Atd002 52017 | Chicago | Illinois | 60657 | — |
| Atd002 52018 | Wheaton | Illinois | 60189 | — |
| Atd002 52012 | New Albany | Indiana | 47150 | — |
| Atd002 52014 | Bowling Green | Kentucky | 42104 | — |
| Atd002 52009 | Troy | Michigan | 48084 | — |
| Atd002 52010 | Omaha | Nebraska | 68144 | — |
| Atd002 52022 | New York | New York | 10029-6574 | — |
| Atd002 52020 | The Bronx | New York | 10455 | — |
| Atd002 52019 | Philadelphia | Pennsylvania | 19114 | — |
| Atd002 52005 | Dallas | Texas | 75230 | — |
| Atd002 52016 | Frisco | Texas | 75033 | — |
| Atd002 52011 | Frisco | Texas | 75034 | — |
| Atd002 52004 | Sugar Land | Texas | 77479 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 40 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07277660, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 25, 2026 · Synced Nov 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07277660 live on ClinicalTrials.gov.